Effect of α 1-acid glycoprotein on the intracellular accumulation of the HIV protease inhibitors saquinavir, ritonavir and indinavir in vitro

British Journal of Clinical Pharmacology

Volumn 51, Issue 1, 2001, Pages 99-102

  Jones, K ^a   Hoggard, P G ^a   Khoo, S ^a   Maher, B ^a   Back, D J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

1 acid glycoprotein; HIV; Intracellular accumulation; Protease inhibitors; U937 cells

Indexed keywords

ANTIVIRUS AGENT; INDINAVIR; OROSOMUCOID; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID SCINTILLATION COUNTING; PRIORITY JOURNAL; PROTEINASE INHIBITION; CELL FRACTIONATION; CELL LINE; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM;

CELL LINE; HIV PROTEASE INHIBITORS; HUMANS; INDINAVIR; OROSOMUCOID; RITONAVIR; SAQUINAVIR; SUBCELLULAR FRACTIONS;

EID: 0034746470     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.2001.01324.x     Document Type: Article

References (14)

1. Protease inhibitors in patients with HIV disease: Clinically important pharmacokinetic considerations
2. Metabolism and disposition of the HIV-1 protease inhibitor ritonavir (ABT-538) in rats, dogs, and humans
3. Clinical pharmacology of HIV protease inhibitors: Focus on saquinavir, indinavir, and ritonavir
4. 1 acid glycoprotein in health and disease
5. 1-acid glycoprotein concentration on the antiviral efficacy of human immunodeficiency virus protease inhibitors
6. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5″-triphosphate with human immunodeficiency virus reverse transcriptase
7. Cellular influx/efflux of protease inhibitors in vitro
8. 1-acid glycoprotein on the anti-human immunodeficiency virus (HIV) activity of the protease inhibitor CGP 61755: A comparitive study with other relevant HIV protease inhibitors
9. 1-acid glycoprotein
10. 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease
11. Protein binding of human immunodeficiency virus protease inhibitor KNI-272 and alteration of its in vitro antiretroviral activity in the presence of high concentrations of proteins
12. SC-52151, a novel inhibitor of the human immunodeficiency virus protease
13. Independent benefit of sufficient drug levels and genotypic analysis in salvage therapy: Pharmacological data of the Viradapt study